Placement Completed

Neurizon Therapeutics placement (September 2025)

A$5m raised

Announced 18 Sep 2025 · ASX: NUZ · A$0.12 cash per share

Advisers

Neurizon Therapeutics

Issuer

Not disclosed

Lead managers

Lead manager
Bookrunner
Issuer
Neurizon Therapeutics
Issuer based in
Australia
Completed
23 Sep 2025
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.